A patient was started on fluphenazine. After few weeks of treatment, he started developing tremors, rigidity, bradykinesia and excessive salivation. First line of management for this patient is
The core concept here is the side effects of antipsychotics, specifically extrapyramidal symptoms (EPS). EPS can include acute dystonia, akathisia, Parkinsonism, and tardive dyskinesia. Fluphenazine is a high-potency first-generation antipsychotic, which is known to block dopamine D2 receptors in the nigrostriatal pathway. Blocking dopamine leads to an imbalance between dopamine and acetylcholine, resulting in Parkinsonian symptoms.
Now, the first line of management for drug-induced Parkinsonism. The options probably include anticholinergics like benztropine or trihexyphenidyl. These work by increasing acetylcholine activity to counteract the dopamine blockage. Alternatively, they might suggest switching to a different antipsychotic with less EPS, like a second-generation one. But the question asks for the first line, so probably the anticholinergic.
Incorrect options might be other treatments like dopamine agonists, but those aren't first line for drug-induced Parkinsonism. Or maybe they suggest stopping the antipsychotic, but that's not always feasible. Also, maybe a benzodiazepine or something else. Need to make sure each distractor is explained properly.
Clinical pearl: Remember that anticholinergics are the first line for managing drug-induced Parkinsonism. Also, distinguish between acute and tardive dyskinesia, as management differs. High-yield fact: Fluphenazine and other typical antipsychotics are more likely to cause EPS than atypical ones.
**Core Concept**
Fluphenazine, a high-potency first-generation antipsychotic, induces extrapyramidal symptoms (EPS) via dopamine D2 receptor blockade in the nigrostriatal pathway. This disrupts the dopaminergic-cholinergic balance, leading to drug-induced Parkinsonism.
**Why the Correct Answer is Right**
The first-line management for drug-induced Parkinsonism is **anticholinergic agents** (e.g., benztropine, trihexyphenidyl). These medications counteract the cholinergic excess caused by dopamine blockade, restoring equilibrium in the basal ganglia. By inhibiting acetylcholine, they alleviate tremors, rigidity, and bradykinesia. Anticholinergics are preferred over dopamine agonists in this context, as the latter may exacerbate symptoms by further antagonizing dopamine receptors.
**Why Each Wrong Option is Incorrect**
**Option A:** *Dopamine agonists* (e.g., levodopa) are contraindicated here. They amplify the dopamine deficiency caused by antipsychotics, worsening symptoms.
**Option B:** *Switching to a second-generation antipsychotic* (e.g., risperidone) may reduce future EPS risk but does not reverse acute Parkinsonism.
**Option D:** *Benzodiazepines* manage akathisia or anxiety, not Parkinsonism. They lack efficacy for tremors or rigidity.
**